Cite

    Siskind, D., Friend, N., Russell, A., McGrath, J. J., Lim, C., Patterson, S., Flaws, D., Stedman, T., Moudgil, V., Sardinha, S., Suetani, S., Kisely, S., Winckel, K., & Baker, A. (2018). coMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine. BMJ open, 8(3), . http://access.bl.uk/ark:/81055/vdc_100137786996.0x000002